Tenet Healthcare CORP DEF 14A proxy statements

Tenet Healthcare reports strong 2025 financial performance, including a 21.4% adjusted EBITDA margin and significant capital deployment, ahead of its 2026 Annual Meeting.

Tenet Healthcare Corporation will hold its annual shareholder meeting virtually on May 22, 2025, to vote on director elections, executive compensation, auditor ratification, and a shareholder proposal on maternal health outcomes.

Tenet Healthcare's proxy statement highlights a transformational year in 2024, marked by portfolio optimization, strong financial performance, and a focus on expanding access to specialty care.

Tenet Healthcare Corporation will hold its annual shareholders meeting virtually on May 22, 2024, to vote on director elections, executive compensation, auditor ratification, and shareholder proposals.

Tenet Healthcare's 2024 proxy statement outlines key proposals for the annual shareholder meeting, including the election of directors, executive compensation, and shareholder initiatives related to risk mitigation and ESG integration.